Diagnosis: harmonising knowledge of the field with the uniqueness of the patient

Philosophical, biological, cultural and clinical aspects were discussed at the 2016 EPA session on the diagnostic process in psychiatry.

The patient is not the illness

 

Prof Michael Musalek (Anton Proksch Institute, Austria) spoke of dehumanisation - when the patient is reduced to a disorder to fix instead of an ill person. But the patient is not the illness.

The patient’s current state does not define them. It is not enough to just record symptoms. Clinicians are part of the process of growth and development.

‘The challenge in the therapeutic process is not only to recognise the significance of the disorders' pathology but also to find ways out of the imagined impossibilities by opening up new possibilities and uncovering resources of the suffering human’ Michael Musalek.

 

Biomarkers

 

Prof Christiane Montag (Charité – Universitätsmedizin Berlin, Germany) concluded that there is a lack of validated methods to measure potential biomarkers. There is not enough evidence to include biomarkers in the classification process, or in clinical diagnostics or response prediction.

 

One world, one language

 

This was the theme of the 1996 World Congress of Psychiatry in Madrid. Twenty years later in the same historic city, the message of the 2016 EPA congress is strikingly similar - towards a common language in European psychiatry.

Prof Marianne Kastrup (speciallæge i psykiatri, Denmark) discussed the importance of a common language in psychiatry that takes cultural dimensions into account. During diagnosis, the patient’s diversity must be considered - how they express mental distress, and their social and cultural context.

The use of the Cultural Formulation - developed as part of DSM-IV - aims to explore cultural, religious and social background. It seeks to understand the patient’s perception and expression of illness, and their treatment expectations. Importantly, it contributes to diagnostics by including cultural factors and their significance. This model supports a review of culture and context in diagnosis.

 

Two people in the room

 

Prof Levent Küey (Istanbul Bilgi University, Turkey) shared his experience of his first interview with a psychiatry patient. After more than an hour, his patient commended him for working hard and pointed out that he was sweating. It struck him that while he was observing his patient; his patient was also observing him. There were two people in the room.

‘Harmonise knowledge of the field with the uniqueness of the patient’ Levent Küey.

The first goal of the clinical encounter and interaction should be setting a strong therapeutic alliance. This relationship improves treatment adherence and outcome.

 

No reductionism

 

Prof Küey emphasised that we need to move away from linear reductionism in which the patient comes into the clinic, is diagnosed and given pills, and then drops out. Clinical work should be a joint, ongoing, reconstruction process.

Prof Montag also addressed the need to move away from reductionism. Personalised psychiatry should target personhood.

Our correspondent’s highlights from the symposium are meant as a fair representation of the scientific content presented. The views and opinions expressed on this page do not necessarily reflect those of Lundbeck.

Country selection
We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil
You are leaving Progress in Mind
Hello
Please confirm your email
We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.
The information on this site is exclusively intented for health care professionals.
All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.
Congress
Register for access to Progress in Mind in your country